Biotech BioLab Holdings, Inc. Announces Investment in Cold Atmospheric Plasma Technology October 24, 2025
Biotech FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease October 23, 2025
Biotech ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors October 22, 2025
Biotech SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform October 21, 2025
Biotech FDA Grants Orphan Drug Designation to Cellenkos’ CK0803 Tregs for Treatment of Amyotrophic Lateral Sclerosis October 20, 2025
Biotech PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer October 19, 2025
Biotech FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States October 17, 2025